Experience with levetiracetam in the treatment of status epilepticus;Erfahrungen mit Levetiracetam in der Behandlung des Status epilepticus

Fortschritte der Neurologie Psychiatrie

Volumn 81, Issue 1, 2013, Pages 21-27

  Rosche J ^a   Pohley, I ^a   Rantsch, K ^a   Walter, U ^a   Benecke, R ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

influence of age; levetiracetam; status epilepticus; success rates

Indexed keywords

ETIRACETAM; HARKOSERIDE;

ANTICONVULSANT THERAPY; ARTICLE; EPILEPTIC STATE; HUMAN; IRRITABILITY; SEDATION; SIDE EFFECT;

ANTICONVULSANTS; EPILEPSIA PARTIALIS CONTINUA; HUMANS; PIRACETAM; STATUS EPILEPTICUS;

EID: 84872897658     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0032-1312951     Document Type: Article

References (92)

1. Rosenow F., Hamer H. M., Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia: 2007; 48 08 82 84 (Pubitemid 350045535)
2. Kälviäinen R. Status epilepticus treatment guidelines. Epilepsia: 2007; 48 08 99 102 (Pubitemid 350045540)
3. Kurthen M., Janzen R. WC, Lerche H. et al. Leitlinien der DGN - Status epilepticus im Erwachsenenalter. http://www.dgn.org/inhalte-a-z/507-leitlinien- der-dgn-status-epilepticus-im-erwachsenenalter (3.7.2011)
4. Shorvon S., Baulac M., Cross H. et al. The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia: 2008; 49 1277 1284
5. Meierkord M., Boon P., Engelsen B. et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol: 2010; 17 348 355
6. Trinka E., Dobesberger J. New treatment options in status epilepticus: a critical review on intravenous levetiracetam. Ther Adv Neurol mDisord: 2009; 2 79 91
7. Arrigo A., Raiteri U., Ardizzone G. Levetiracetam monotherapy for the treatment of partial status epilepticus in a patient following a liver transplant. Epilpesia: 2004; 45 03 145
8. Zaatreh M. M. Levetiracetam in porphyric status epilepticus: a case report. Clin Neuropharmacol: 2005; 28 243 244 (Pubitemid 41579624)
9. Pato-Pato A., Rana-Martinez N., Lorenzo-Gonzáles J. R. et al. The value of an oral solution of levetiracetam in status epilepticus. Rev Neurol: 2006; 42 768 (Pubitemid 47378343)
10. Donaire A., Carreno M., Gómez B. Cortical laminar necrosis related to prolonged focal status epilepticus. J Neurol Neurosurg Psychiatry: 2006; 77 104 106 (Pubitemid 43022706)
11. Feleppa M. MF, De Cillis P. PDC, Esposito G. GE. Refractory status epilepticus treated by nasogastric levetiracetam: a case report of excellent neurological recovery. Epilepsia: 2006; 47 04 158
12. Veldkamp A. I., Swart E. L. Unanticipated recovery from a status epilepticus after administration of levetiracetam. Br J Clin Pharmacol: 2006; 62 734 735
13. Pastor-Milán E., González-Torres V., Vilches R. Utilidad del levetiracetam en el estado epiléptico. Rev Neurol: 2006; 41 508 509
14. Shoemaker M. T., Rotenburg J. S. Levetiracetam for the treatment of neonatal seizures. J Child Neurol: 2007; 22 95 98 (Pubitemid 46860448)
15. Farooq M. U., Naravetla B., Majid A. et al. IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care: 2007; 7 36 39 (Pubitemid 350242677)
16. Trabacca A., Profice P., Costanza M. C. et al. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report. J Child Neurol: 2007; 22 639 641 (Pubitemid 46951512)
17. Zenkov L. R., Shevtsov K. I., Gubanova N. B. Levetiracetam (keppra) in the treatment of refractory status epilepticus. Zh Nevrol Psikhiatr Im S S Korsakova: 2007; 107 71 74
18. Alehan F., Ozcay F., Haberal M. The use of levetiracetam in a child with nonconvulsive status epilepticus. J Child Neurol: 2008; 23 331 333 (Pubitemid 351247627)
19. Goraya J. S., Khurana D. S., Valencia I. et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol: 2008; 38 177 180 (Pubitemid 351221234)
20. Bhatia R., Vibha D., Srivastava M. V. et al. Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria. Epilepsia: 2008; 49 934 936 (Pubitemid 351652434)
21. Altenmüller D. M., Kühn A., Surges R. et al. Termination of absence status epilepticus by low-dose intravenous levetiracetam. Epilepsia: 2008; 49 1289 1290 (Pubitemid 351991407)
22. Callén-Soto A., Pérez-Pérez S., Robles-Del Olmo B. Non-convulsive epileptic status reverted with intravenous levetiracetam. Rev Neurol: 2008; 47 501 502
23. Abend N. S., Florance N., Finkel R. S. et al. Intravenous levetiracetam terminates refractory focal status epilepticus. Neurocrit Care: 2009; 10 83 86
24. Carota A., Novy J., Rossetti A. O. Symptomatic complex partial status epilepticus manifesting as utilization behavior of a mobile phone. Epilepsy & Behavior: 2009; 14 553 555
25. Elouni B., Salem C. B., Biour M. Levetiracetam-induced pancytopenia. Ann Pharm: 2009; 43 985
26. Cilio M. R., Bianchi R., Balestri M. et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res: 2009; 86 66 71
27. Pestana Knight E. M., Gilman S., Selwa L. Status epilepticus in Wilsons disease. Epileptic Disord: 2009; 11 138 143
28. Haase C. G., Hopmann B. Epilepsia partialis continua successfully treated with levetiracetam. J Neurol: 2009; 256 1020 1021
29. Haberlandt E., Sigl S. B., Scholl-Buergi S. et al. Levetiracetam in the treatment oft two children with myoclonic status epilepticus. Eur J Paediatr Neurol: 2009; 13 546 549
30. Schulze-Bonhage A., Hefft S., Oehl B. Termination of complex partial status epilepticus by intravenous levetiracetam. J Neurol Neurosurg Psychiatry: 2009; 80 931 933
31. Eggers C., Burghaus L., Fink G. R. et al. Epilepsia partialis continua responsive to intravenous levetiracetam. Seizure: 2009; 18 716 718
32. Weber P. Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome. J Child Neurol: 2010; 25 393 396
33. Da-Silva S. S., Wong R., Coquillon P. Partial-exchange transfusion: an effective method for preventing mortality in a child with propofol infusion syndrome. Pediatrics: 2010; 125 e1493 e1499
34. Turpin-Fenoll L., Millan-Pascual J., Navarro-Munoz S. et al. Uso de lacosamida oral en un paciente con estado epileptico parcial refractario. Rev Neurol: 2010; 50 603 606
35. Patil H. V., Patil V. C., Rajmane V. et al. Successful treatment of cerebral toxoplasmosis with cotrimoxazole. Indian J Sex Transm Dis: 2011; 32 44 46
36. Devarajan J., Siyam A. M., Alexopoulos A. V. et al. Non-convulsive status epilepticus in the postanesthesia care unit following meningioma excision. Can J Anesth: 2011; 58 68 73
37. Chen L. LK, Haneef Z., Dorsch A. et al. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure: 2011; 20 263 265
38. Krause L. U., Brodowski K. O., Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy & Behavior: 2011; 20 725 727
39. Laroche S. M., Shivdat-Nanhoe R. Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus. Seizure: 2011; 20 505 508
40. Shiloh-Malawsky Y., Fan Z., Greenwood R. et al. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure: 2011; 20 586 588
41. Torres-Cano N., Giner-Bayarri P., Chilet-Chilet M. R. et al. Estado epileptico non convulsive persistente. Rev Neurol: 2011; 53 255 256
42. Ko S. B., Ortega-Gutierrez S., Choi H. A. et al. Status Epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest. Arch Neurol: 2011; 68 1323 1326
43. Rossetti A. O., Bromfield E. B. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol: 2005; 54 34 38 (Pubitemid 41328732)
44. Mehta S., Wu B. Y. Case Series: Treatment with levetiracetam in nonconvulsive status epilepticus. Epilepsia: 2005; 46 08 220
45. Saguer M., Estermann K., Caravias G. et al. Treatment in SE (status epilepticus) in ICU with levetiracetam. Neurology: 2006; 66 02 p A38
46. Patel N. C., Landan I. R., Levin J. et al. The use of levetiracetam in refractory status epilepticus. Seizure: 2006; 15 137 141
47. Rossetti A. O., Bromfield E. B. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav: 2006; 8 651 654
48. Falip M., Carreno M., Amaro S. et al. Use of levetiracetam in hospitalized patients. Epilepsia: 2006; 47 2186 2188 (Pubitemid 44952276)
49. Rupprecht S., Franke K., Fitzek S. et al. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res: 2007; 73 238 244
50. Reinshagen A., Holler M., Fritz K. et al. Intravenous levetiracetam in refractory status epilepticus: case reports. Epilepsia: 2007; 48 03 20
51. Seminario N. A., Bateman L. M., Seyal M. The use of intravenous levetiracetam for status epilepticus. Epilepsia: 2007; 48 06 36
52. Khongkhatithum C., Goyal M. Use of intravenous levetiracetam in a pediatric tertiary care hospital. Epilsepsia: 2007; 48 06 354
53. Morton L., Powers K., Teasley J. Use of intravenous (iv) levetiracetam in 3cases of refractory status epilepticus (SE) in pediatric patients. Epilepsia: 2007; 48 06 357 358
54. Broessner G., Dobesberger J., Seppi K. et al. Intravenous levetiracetam in seizure emergency situations including status epilepticus. Epilepsia: 2007; 48 08 103 104
55. Rüegg S., Naegelin Y., Hardmeier M. et al. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav: 2008; 12 477 480
56. Knake S., Gruener J., Hattemer K. et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry: 2008; 79 588 589 (Pubitemid 351571881)
57. Eckert M., Besser R. Rapid intravenous infusion of levetiracetam. Akt Neurol: 2008; 35 211 213
58. Gallentine W. B., Hunnicutt A. S., Husain A. M. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav: 2009; 14 215 218
59. Beyenburg S., Reuber M., Maraite N. Intravenous levetiracetam for epileptic seizure emergencies in older people. Gerontology: 2009; 55 27 31
60. Nau K. M., Divertie G. D., Valentino A. K. et al. Safety and efficacy of levetiracetam for critically ill patients with seizures. Neurocrit Care: 2009; 11 34 37
61. Uges J. W., van Huizen M. D., Engelsman J. et al. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Epilepsia: 2009; 50 415 421
62. Möddel G., Bunten S., Dobis C. et al. intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry: 2009; 80 689 692
63. Kirmani B. F., Crisp E. D., Kayani S. et al. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol: 2009; 41 37 39
64. Abend N. S., Monk H. M., Licht D. J. et al. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med: 2009; 10 505 510
65. Eue S., Grumbt M., Müller M. et al. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav: 2009; 15 467 469
66. Berning S., Boesebeck F., van Baalen A. et al. Intravenous levetiracetam as treatment for status epilepticus. J Neurol: 2009; 256 1634 1642
67. Gámez-Leyva G., Aristín J. L., Fernández E. et al. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series. CNS Drugs: 2009; 23 983 987
68. Tripathi M., Vibha D., Choudhary N. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure: 2010; 19 109 111
69. Abend N. S., Dlugos D. J., Hahn C. D. et al. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists. Neurocrit Care: 2010; 12 382 389
70. Fattouch J., Di Bonaventura C., Casciato S. et al. Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol Scand: 2010; 121 418 421
71. Modur P. N., Milteer W. E., Zhang S. Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetive and prolonged seizures. Epilepsia: 2010; 51 1078 1082
72. Reiter P. D., Huff A. D., Knupp K. G. et al. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol: 2010; 43 117 121
73. Aiguabella M., Falip M., Villanueva V. et al. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study. Seizure: 2011; 20 60 64
74. Parkerson K. A., Reinsberger C., Chou S. H. et al. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy & Behavior: 2011; 20 48 51
75. Mameniskiene R., Bast T., Bentes C. et al. Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia: 2011; 52 1168 1176
76. Kellinghaus C., Berning S., Immisch I. et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand: 2011; 123 137 141
77. Koubeissi M. Z., Mayor C. L., Estephan B. et al. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand: 2011; 123 142 146
78. Albers J. M., Möddel G., Dittrich R. et al. Intravenous lacosamide - an effective add-on treatment of refractory status epilepticus. Seizure: 2011; 20 428 430
79. Goodwin H., Hinson H. E., Shermock K. M. et al. The use of lacosamide in refractory status epilepticus. Neurocrit Care: 2011; 14 348 353
80. Alvarez V., Januel J. M., Burnand B. et al. Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia: 2011; 52 1292 1296
81. Rantsch K., Walter U., Wittstock M. et al. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure: 2011; 20 529 532
82. Swisher C. B., Doreswamy M., Gingrich K. J. et al. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Neurocrit Care: 2012; 16 109 113
83. Misra U. K., Kalita J., Maurya P. K. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol: 2012; 259 645 648
84. Eriksson K., Metsäranta P., Huhtala H. et al. Treatment delay and the risk of prolonged status epilepticus. Neurology: 2005; 65 1316 1318 (Pubitemid 41508236)
85. DeLorenzo R. J., Towne A. R., Pellock J. M. et al. Status epilepticus in children, adults, and the elderly. Epilepsia: 1992; 33 04 15 25
86. Towne A. R., Pellock J. M., Ko D. et al. Determinants of mortality in status epilepticus. Epilepsia: 1994; 35 27 34 (Pubitemid 24074462)
87. Rossetti A. O., Logroscino G., Milligan T. A. et al. Status Epilepticus Severity Score (STESS). A tool to orient early treatment strategy. J Neurol: 2008; 255 1561 1566
88. Trinka E. What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, Phenobarbital, valproate, and levetiracetam? Epilepsia: 2009; 50 12 40 43
89. Jaques L., Rossetti A. O. Newer antiepileptic drugs in the treatment of status epilepticus: Impact on prognosis. Epilepsy Behav: 2012; ahead of print.
90. Harden C. Safety profile of Levetiracetam. Epilepsia: 2001; 42 04 36 39 (Pubitemid 32802086)
91. Lyseng-Williamson K. A. Spotlight on levetiracetam in epilepsy. CNS Drugs: 2011; 25 901 905
92. Fröscher W., Raape J., Rösche J. Reversibler GGT-Anstieg bei einer Levetiracetam-Kombinationstherapie. Akt Neurol: 2005; 32 537 540 (Pubitemid 41807765)